Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez-Rueda, J.
Right arrow Articles by Alarcón-Segovia, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Martinez-Rueda, J.
Right arrow Articles by Alarcón-Segovia, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 5, No. 2, 113-119 (1996)
DOI: 10.1177/096120339600500205
© 1996 SAGE Publications

Factors associated with fetal losses in severe systemic lupus erythematosus

JO Martinez-Rueda

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán. Mexico DF, Mexico City

CA Arce-Salinas

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán. Mexico DF, Mexico City

A. Kraus

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán. Mexico DF, Mexico City

J. Alcocer-Varela

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán. Mexico DF, Mexico City

D. Alarcón-Segovia

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán. Mexico DF, Mexico City

We evaluated factors associated with fetal losses in patients with severe lupus in a nested case-control study. We assessed separately 73 pregnancies that occurred in 46 women from a cohort of 633 Systemic Lupus Erythematosus (SLE) patients. They had at least one preg nancy after SLE diagnosis, one or more of our severity criteria and all had taken immuno suppressive drugs. Included data were related to disease severity, anti-phospholipid syndrome (APS), anticardiolipin antibodies (a-CL ab), and drugs received during preg nancy. Cases were pregnancies with fetal wastage; controls were pregnancies with live-born children.

The mean age at pregnancy was 26.6 ± 4.5 years. Cases had longer disease duration, 6.1 ± 3.5 years vs 4.5 ± 4.3 of controls (p = 0.02); higher prevalence of renal involvement, hemolysis and recurrent venous thrombosis (p < 0.05); they also tended to have a greater prevalence of a-CL ab, and previous fetal losses (p = 0.06). Cases used azathioprine more frequently than controls (p = 0.04). Univariate analysis showed an association of renal involvement, hemolytic anemia, azathioprine or cyclophosphamide prescription during pregnancy, previous fetal losses and APS with fetal wastage. Immunosuppressive drugs and the APS remained significant in the multivariate analysis (p = 0.05; F = 0.01). Factors related with fetal losses in women with severe SLE were: longer disease duration, ingestion of immunosuppressive drugs during pregnancy and any related manifestation of APS. We did not find macroscopic malformations in live-children of women that took azathioprine during pregnancy.

Key Words: systemic lupus erythematosus • fetal losses • immunosuppressive drugs • azathiop rine • risk factors • antiphospholipid syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?